Survival benefit of Asian females in the era of targeted therapy for advanced lung cancer
| Autor: | Benjamin Levy, Michael L. Grossbard, Lena Masri, Daniel Jacob Becker |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Lung business.industry medicine.medical_treatment Fda approval respiratory system medicine.disease EGFR Tyrosine Kinase Inhibitors respiratory tract diseases Targeted therapy medicine.anatomical_structure Survival benefit Internal medicine medicine Erlotinib Lung cancer business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 32:e17659-e17659 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | e17659 Background: Development of the EGFR tyrosine kinase inhibitors (TKI’s) and FDA approval of erlotinib in 2004 began a decade of advances in targeted therapy for advanced lung cancer. Lung ade... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|